The three most recommended brands of nintedanib

Nintedanib (Nintedanib) is a drug used to treat idiopathic pulmonary fibrosis (IPF), chronic fibrosing interstitial lung disease (ILD), and systemic sclerosis-related interstitial lung disease (SSc-ILD). There are several brands of nintedanib on the market that are widely recommended for their efficacy and safety.

First of all, Ofev (Ofev) is an original drug produced by the German company Bayer and is the first brand of nintedanib to be launched. Vigat is known for its effectiveness and safety in clinical trials and has been widely used in patients as indicated. The drug is included in the scope of Class B reimbursement according to the national medical insurance policy, making it more economically accessible. The packaging specifications provided by Vegat are 100mg and 150mg. Each box usually contains 30 pills, and the price is about more than 4,000 yuan. Although this price is higher, considering its efficacy, it is still accepted by many patients.

Secondly, there are also original drugs developed by the German company Bayer on the Turkish and Indian markets. Its specifications include100mg and 150mg, and the package is 60 tablets. The price of these products is usually between more than 4,000 to 5,000 yuan, and the specific price is affected by exchange rate fluctuations. Since the production standards of these drugs are similar to the original drugs, they are also the choice recommended by many doctors, especially in some areas with relatively good economic conditions.

Finally, there are some generic drugs from India on the market, such asBDR Company, Grandmark Pharmaceuticals and Laos ASEAN Pharmaceuticals. Although the price of these generic drugs is relatively more economical, usually around 600 yuan, their ingredients are basically similar to the original drugs, so they can be used as an alternative choice for patients to a certain extent. The emergence of these generic drugs has provided more treatment options for patients with heavy financial burdens, especially for patients who cannot afford the cost of original drugs.

Reference materials:https://en.wikipedia.org/wiki/Nintedanib